These Australians dug into the 'junk' of millions of cells. It could be a drug game-changer
Could the answer to treating some of Australia's most common diseases lie in our genes?
Could the answer to treating some of Australia's most common diseases lie in our genes?
M42 Group CEO Dimitris Moulavasilis discusses how the Abu Dhabi-based healthcare company is combining artificial intelligence, genomics and clinical services to reshape healthcare. He explores the groupβs international expansion, the Emirati Genome Programme and the potential for technology to help doctors identify health risks earlier and move healthcare towards prevention rather than treatment.